Shareholders
List of 30 largest shareholders of Alvotech as of December 31 2022
Rank |
Shareholder |
% |
1 |
Aztiq Pharma Partners S.a r.l. |
40.7% |
2 |
Alvogen Lux Holdings S.a r.l. |
35.8% |
3 |
Oaktree |
3.6% |
4 |
Bracebridge Capital* |
3.4% |
5 |
YAS Holding* |
3.0% |
6 |
Strüngmann family holdings |
1.9% |
7 |
Fuji Pharma |
1.8% |
8 |
Baxter Healthcare |
1.1% |
9 |
Celtic* |
1.0% |
10 |
Shinan Healthcare Fund |
0.6% |
11 |
Littlejohn & Co. |
0.6% |
12 |
Morgan Stanley & Co. |
0.5% |
13 |
Islandssjodir* |
0.5% |
14 |
Richard Davies |
0.5% |
15 |
Hvalur |
0.5% |
16 |
Kvika* |
0.4% |
17 |
Suvretta Capital Management |
0.4% |
18 |
Temasek Holdings |
0.4% |
19 |
Stefnir* |
0.3% |
20 |
Vestmannaeyja Pension Fund |
0.2% |
21 |
JV ehf. |
0.2% |
22 |
Sjova-Almennar Insurance hf. |
0.2% |
23 |
Landsbref* |
0.2% |
24 |
Sculptor* |
0.2% |
25 |
Arion |
0.1% |
26 |
NJGC Holdings, L.P. |
0.1% |
27 |
Akta* |
0.1% |
28 |
Fossar* |
0.1% |
29 |
Tharabakki ehf |
0.1% |
30 |
VGJ ehf. |
0.1% |
|
Other shareholders total |
1.5% |
Percentage based on 248,659,506 shares outstanding on December 31 2022, and excludes 27.072.166 treasury shares Based on data from Nasdaq Iceland and Compushare
* Represents aggregated holdings in multiple funds